Trevi Therapeutics Inc (TRVI)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

195 CHURCH STREET NEW HAVEN, CT 06510

Trevi Therapeutics, Inc. operates as a pharmaceutical company. The Company develops nalbuphine ER for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis and levodopa-induced dyskinesia. Trevi Therapeutics serves patients in the United States.

Data as of 2021-05-08 12:02:16 -0400
Market Cap41.847 Million Shares Outstanding19.927 Million Avg 30-day Volume32.467 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.95 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.88558 52-week High/Low8.5 / 2.05 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TRVI instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 19 17 11.76% 4 (0.24%) 3 (0.19%) 33.33%
13F shares: 13.008 Million 13.264 Million -1.93% 1.34 Million 1.426 Million -6.02%
% Ownership 70.7674 72.1608 -1.93% 7.2912 7.758 -6.02%
New Positions: 4 3 33.33% 1 1 0.0%
Increased Positions 3 2 50.0% 1 1 0.0%
Closed Positions 2 3 -33.33%
Reduced Positions 2 4 -50.0% 1
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TRVI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TRVI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GALLETTA CHRISTOPHER SEE REMARKS

  • Officer
25,000 2021-04-13 2

GOOD JENNIFER L PRESIDENT & CEO

  • Officer
  • Director
0 2021-02-17 1

MUSCOLO FRANK P CONTROLLER

  • Officer
0 2021-02-17 1

SEITER CHRISTOPHER CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-17 1

SCIASCIA THOMAS CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-17 1

FORBES WILLIAM P CHIEF DEVELOPMENT OFFICER

  • Officer
0 2021-02-01 2

COLANGELO DOMINICK

  • Director
0 2020-06-29 2

HEFFERNAN MICHAEL THOMAS

  • Director
0 2020-06-11 1

MEEKER DAVID P

  • Director
0 2020-06-11 1

VANLENT ANNE

  • Director
0 2020-06-11 1

MATHERS EDWARD T

  • Director
0 2020-06-11 1

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
4,824,883 2020-04-03 0

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • 10% Owner
5,937,998 2020-04-03 0

SANDELL SCOTT D

  • 10% Owner
5,937,998 2020-04-03 0

MAKOWER JOSHUA

  • 10% Owner
5,937,998 2020-04-03 0

MAKHZOUMI MOHAMAD

  • 10% Owner
5,937,998 2020-04-03 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
5,937,998 2020-04-03 0

CHANG CARMEN

  • 10% Owner
5,937,998 2020-04-03 0

BEHBAHANI ALI

  • 10% Owner
5,937,998 2020-04-03 0

BASKETT FOREST

  • 10% Owner
5,937,998 2020-04-03 0

WALKER PAUL EDWARD

  • 10% Owner
5,937,998 2020-04-03 0

SONSINI PETER W.

  • 10% Owner
5,937,998 2020-04-03 0

MAZABRAUD YANN SEE REMARKS

  • Officer
0 2020-02-13 0

BRETT-SMITH HELENA CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-02-13 0

CASSELLA JAMES V

  • Director
0 2020-02-13 0

BARRIS PETER J

  • 10% Owner
4,438,562 2019-05-09 0

DRAKE DEBRA A

  • 10% Owner
62,540 2019-05-09 0

OMEGA FUND V, L.P.

OMEGA FUND V GP, L.P.

OMEGA FUND V GP MANAGER, LTD.

MITSAK ANNA GUYER

  • Director
  • 10% Owner
1,063,408 2019-05-09 0

LUNDBECKFOND INVEST A/S

  • 10% Owner
1,151,544 2019-05-09 0

MELLON FAMILY INVESTMENT CO V

MFIC V, LLC

  • 10% Owner
347,156 2019-05-09 0

DRAKE PETER F

  • 10% Owner
62,540 2019-05-09 0

AGGER METTE KIRSTINE

  • Director
1,151,544 2019-05-09 0

RICHARD KING MELLON FOUNDATION

  • 10% Owner
347,157 2019-05-09 0

APERTURE VENTURE PARTNERS IV, L.P.

APERTURE VENTURES IV MANAGEMENT, LLC

  • 10% Owner
344,963 2019-05-09 0

MOTT DAVID M

  • 10% Owner
4,438,562 2019-05-09 0

OSHEA WILLIAM J

  • 10% Owner
114,080 2019-05-09 0

O'SHEA WILLIAM J

  • 10% Owner
15,034 2019-05-07 0

NADAV ERAN

  • Director
0 2019-05-07 0

MITSAK ANNA GUYER

  • Director
0 2019-05-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GALLETTA CHRISTOPHER - Officer SEE REMARKS

2021-04-15 19:04:18 -0400 2021-04-13 A 25,000 a 25,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TREVI THERAPEUTICS INC TRVI 2021-05-10 22:15:04 UTC -8.5356 8.5856 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 21:45:02 UTC -8.5424 8.5924 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 21:15:02 UTC -8.5424 8.5924 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 20:45:03 UTC -8.5424 8.5924 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 20:15:03 UTC -8.5424 8.5924 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 19:45:03 UTC -8.5424 8.5924 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 19:15:03 UTC -8.5424 8.5924 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 18:45:03 UTC -8.5504 8.6004 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 18:15:03 UTC -8.5504 8.6004 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 17:45:02 UTC -8.5504 8.6004 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 17:15:03 UTC -8.5504 8.6004 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 16:45:03 UTC -8.5387 8.5887 80000
TREVI THERAPEUTICS INC TRVI 2021-05-10 16:15:03 UTC -8.5387 8.5887 90000
TREVI THERAPEUTICS INC TRVI 2021-05-10 15:45:03 UTC -8.5387 8.5887 90000
TREVI THERAPEUTICS INC TRVI 2021-05-10 15:15:03 UTC -8.5387 8.5887 90000
TREVI THERAPEUTICS INC TRVI 2021-05-10 14:45:04 UTC -8.5423 8.5923 90000
TREVI THERAPEUTICS INC TRVI 2021-05-10 14:15:04 UTC -8.5423 8.5923 90000
TREVI THERAPEUTICS INC TRVI 2021-05-10 13:45:04 UTC -8.5423 8.5923 90000
TREVI THERAPEUTICS INC TRVI 2021-05-10 13:15:03 UTC -8.5423 8.5923 90000
TREVI THERAPEUTICS INC TRVI 2021-05-10 12:45:02 UTC -8.5423 8.5923 90000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments